| First Author | Taketo MM | Year | 2000 |
| Journal | Cytokine Growth Factor Rev | Volume | 11 |
| Issue | 1-2 | Pages | 147-57 |
| PubMed ID | 10708962 | Mgi Jnum | J:61211 |
| Mgi Id | MGI:1354571 | Doi | 10.1016/s1359-6101(99)00038-6 |
| Citation | Taketo MM, et al. (2000) Gastro-intestinal tumorigenesis in Smad4 mutant mice. Cytokine Growth Factor Rev 11(1-2):147-57 |
| abstractText | The SMAD4 gene plays a key role in the TGF-beta signaling pathway. We inactivated its mouse homolog Smad4. The homozygous mutants were embryonically lethal, whereas the heterozygotes were viable and fertile. Although young heterozygotes appeared normal, old mice developed gastric and duodenal polyps similar to human juvenile polyps characterized by abundant stroma and eosinophilic infiltrations. These data are consistent with the reports that a subset of human juvenile polyposis kindreds carry germline mutations in the SMAD4 gene. We then introduced the Smad4 mutation into the Apc(Delta716) knockout mice, a model for human familial adenomatous polyposis. Because both Apc and Smad4 are located on mouse chromosome 18, we constructed by meiotic recombination compound heterozygotes carrying both mutations on the same chromosome. In such mice, intestinal polyps developed into more malignant tumors than those in the simple Apc(Delta716) heterozygotes, showing an extensive stromal cell proliferation and strong submucosal invasion. These results indicate that mutations in SMAD4 play a significant role in the malignant progression of colorectal tumors. |
